Canaccord reiterates Zscaler stock rating on sales force transition

Zscaler shares are being supported by Canaccord’s Buy rating and $210 price target, despite conservative fiscal 2027 ARR growth guidance of 16.6%–17.4% (implying net new ARR deceleration to ~4% at the midpoint). The note highlights 76.8% gross margin and 25% LTM revenue growth, while projecting near-term caution from a sales-force transition and assumptions of zero net new ARR contribution from Red Canary. Analysts also point to strong Q4 performance (multiple metric beats, AI Security for AI bookings +50% QoQ and pipeline +75% QoQ), driving multiple price target lifts (e.g., Cantor $225, Guggenheim $214, Wells Fargo $215, BMO $200), suggesting upside from the ~$177.80 current price toward ~8x CY27E sales valuation.

Analysis

The market is likely over-discounting the near-term sales disruption and underpricing the second-order benefit of a cleaner go-to-market reset. In security software, a temporary booking slowdown often matters less than whether the product cycle is intact; here the AI-security pipeline suggests demand is not the issue, so the key question is conversion timing. That favors a re-rating if the company can stabilize net-new ARR by the second half of the next fiscal year.

Winners are the incumbents with durable platform breadth and the fastest enterprise cross-sell, while losers are vendors that need flawless sales execution to defend share. If ZS re-accelerates, it pressures peers like PANW and CRWD on valuation because it removes the easy bear case that growth is structurally broken; if it does not, the stock can de-rate quickly despite decent margins. The long-run setup is attractive because the current valuation implies the market is treating AI security as optionality, not as a monetizable product line.

Contrarian risk: consensus may be too comfortable assuming the transition is a one-half issue. If the sales reset drags, the base-case ARR profile can step down for multiple quarters, and the stock’s apparent cheapness can evaporate fast if growth slips below the company’s own guide. The cleanest falsifier is a follow-up quarter where new ARR fails to inflect or AI-security pipeline does not convert into recognizable bookings.

Key Decisions for Investors

• Build a tactical long ZS position on post-event weakness and hold 6-12 months; thesis is valuation gap closes as sales transition normalizes and AI-security monetization starts to show up in bookings.
• Use a pair trade: long ZS / short PANW for relative-value exposure to security software re-rating, with the long leg benefiting if ZS’s guide proves conservative and the short leg hedging sector beta.
• If you want convexity, buy ZS 9-12 month call spreads rather than outright stock; the catalyst path is second-half fiscal-year execution, so paying for longer-dated optionality is preferable to short-dated gamma.
• Do not add aggressively until the next quarterly read on net-new ARR and enterprise conversion; if those metrics stay soft for two reporting periods, treat the thesis as broken rather than a timing issue.
• Watch for a reversal signal if shares regain and hold the post-guidance gap on rising volume; failure to do so would suggest the market is using the event to de-rate the multiple, not to look through it.